Categories: world

Democrats who take key leadership work have fooled millions from the pharmaceutical industry

This story is from Kaiser Health News. Three of the legislators who will lead the Chamber next year, when Congress…

This story is from Kaiser Health News.

Three of the legislators who will lead the Chamber next year, when Congress focuses on drug cloudrocketing costs, are among the largest recipients of campaign contributions from the pharmaceutical industry showing a new KHN analysis

On Wednesday, the House Democrats Rep. Steny Hoyer from Maryland to serve as the next major leader and rep James Clyburn in South Carolina as Majority Whip and made them the 2nd and 3rd most powerful Democrats whose party is gaining control over the house in January.

Both legislators have received more than $ 1

Supplementary rep Nancy Pelosi, California Democrat is expected to be the next speaker; the three-person Democratic leadership has collected more than $ 2.3 million in total in campaign contributions from drug users since the 2007-08 election period, according to KHN’s database.

High drug prices arose as a major campaign issue in 2018. With nearly half of Americans saying they were worried about drug costs last summer, many Democrats said voters that they would address the issue at the next congress. But the big sum of money coming to key Democrats and Republicans poses questions about whether Congress should take on the pharmaceutical industry.

Over the last decade, Congressmen from both parties have received about $ 81 million from 68 pharma-PAC

Brendan Fischer, who heads federal reform programs in the Non-Partial Campaign Legal Center, said drug users, as well as other wealthy industries, “Democrats and Republicans have discussed how to take action on prescription drug prices, and pharmaceutical companies are likely to expect large contributions to help them maintain and influence powerful legislators,” he said. 19659007] McCarthy, who has close ties with President Donald Trump, has received more than $ 1.08 million from Drugmaker PAC since 2007. Accord to the latest information, which runs through September, he received about $ 250,000 in this election cycle.

The fourth The legislator of over $ 1 million is late Richard Burr, a North Carolina republ ikan who serves both the Senate Committee on Health, Education, Labor and Pensions and the Senate Committee for Finance. North Carolina is also home to a number of research universities and drug company headquarters.

While campaign contributions may seem tantalizing as a metric to influence, industries do not necessarily need to buy votes with their money. More likely they buy the access. A major donation from a PAC may increase the chances of its lobbyists having a meeting with an influential legislator, for example.

Clyburn, who likes Hoyer, has been leading democratic leader since 2007, has received more from drugmaker PACs in the past decade than any other member of Congress – more than $ 1.09 million. In 2018, the constituency received at least $ 170,000 despite believing his Republican opponent in his secure democratic district.

A party leader and the highest rated African American in Congress, Clyburn has had relations with the pharmaceutical industry over the years. In 2013, he was a prominent speaker at a conference hosting PhRMA, the industry’s leading trading group. The conference was held at James E. Clyburn Research Center at the Medical University of South Carolina, a hub for biopharmaceutical research.

In the fall, Hoyer billed dollar dollars in drugmaker PAC contributions over the past decade, collecting more than $ 1.02 million since 2007 and more than $ 128,000 this election cycle.

“Mr. Hoyer’s position on legislation is based on the best interests of his stakeholders and the American people, and he has made it clear that the new congress will address rising healthcare costs and prescription drug costs” says Mariel Saez, a speaker from Hoyer. 19659003] Clyburn, McCarthy and Pelosis Office did not respond to requests for comments.

Pelosi, unlike her alternates, has received nearly $ 193,000 in total from drugmaker PACs in the last decade. In the month before the mid-term election, she intensified her calls for measures to control drug prices and said on election day that she believed that Democrats could find “common ground” with Trump to address the problem.

Members usually also draw large sums from the industries they monitor. Rope. Frank Pallone of New Jersey, the Democrat, who is expected to be chairman of the House Committee on Energy and Commerce, received nearly $ 169,000 from this drug cycle drug drug PAC, according to KHN’s database. Since 2007 he has collected more than 840,000 dollars.

Similarly, ropes. Greg Walden, the Oregon Republic who ends his mandate as the chairman of the committee, received $ 302 300, most of any member of this election cycle in contributions from drugmaker PAC.

On the other hand, ropes. Elijah Cummings, Maryland Democrat, who is expected to lead the House of Commons for Monitoring and Government Reform, has attracted the lowest drugmaker cash and receives only 18,500 dollars since the 2007-08 parliamentary term. He has stated that he intends to target pharmaceutical companies next year when examining climate costs.

Kaiser Health News (KHN) is a national health policy news service. It is an editorial independent program by Henry J. Kaiser Family Foundation, not affiliated with Kaiser Permanente.

Published by